Akira Wakana

Efficacy, safety, and immunogenicity of a quadrivalent HPV vaccine in Japanese men: A randomized, Phase 3, placebo-controlled study

Hiroshige Mikamo, Yuka Yamagishi, Shinya Murata et al. · Vaccine · 2019 · 54 citations · Full text

Restricted mean survival time as a summary measure of time‐to‐event outcome

Takahiro Hasegawa, Saori Misawa, Shintaro Nakagawa et al. · Pharmaceutical Statistics · 2020 · 45 citations

Single and multiple dose pharmacokinetics and pharmacodynamics of omarigliptin, a novel, once‐weekly dipeptidyl peptidase‐4 inhibitor, in healthy Japanese men

Saori Tsuchiya, Evan Friedman, Carol Addy et al. · Journal of Diabetes Investigation · 2016 · 25 citations · Full text

A Performance Comparison of Maximum Contrast Methods to Detect Dose Dependency

Isao Yoshimura, Akira Wakana, Chikuma Hamada · Drug Information Journal · 1997 · 20 citations

Engineering, Medical Imaging, Medicine +14

A Japanese nationwide survey of 23-valent pneumococcal capsular polysaccharide vaccine (PPSV23) coverage among patients with chronic medical condition aged 50 and older

Kenji Kawakami, Atsushi Nakamura, Akira Wakana et al. · Human Vaccines & Immunotherapeutics · 2019 · 17 citations · Full text

Immunodeficiencies, Ppsv23 Immunization, Population Health Sciences +21